Profile
Sector:
HealthcareIndustry:
Medical DistributionCountry:
FranceIPO:
01 August 1997Website:
http://www.edap-tms.comNext earnings report:
23 August 2024Last dividends:
N/ANext dividends:
N/APrice
regular market | 27 min agoDividend
Analysts recommendations
Institutional Ownership
EDAP Latest News
EDAP TMS (NASDAQ: EDAP) Q1 2024 Earnings Call Transcript on May 16, 2024 at 8:30 AM ET featuring Company Representatives John Fraunces, Ryan Rhodes, and Ken Mobeck. Conference Call Participants include Michael Sarcone, Frank Takkinen, Jason Bednar, and Swayampakula Ramakanth. Welcome to the EDAP TMS First Quarter 2024 Earnings Conference Call.
EDAP TMS reported Q2 2023 revenues of $15.52 million, a 0.9% YoY growth that missed estimates. In Q2 2023, HIFU's total revenue growth stood at 63.6% (YoY). The procedure growth of Focal One shot up 85% (YoY). EDAP's share price has declined 21.50% YoY and is trading almost 50% below its 52-week-high.
EDAP TMS S.A. is a French developer of minimally invasive medical devices for urological diseases. The company operates in three segments: High Intensity Focused Ultrasound, Extracorporeal ShockWave Lithotripsy, and Distribution Services. High Intensity Focused Ultrasound is gaining traction as a treatment for prostate cancer and has potential applications in rectal endometriosis.
EDAP TMS S.A. (NASDAQ:EDAP ) Q2 2023 Earnings Conference Call August 24, 2023 8:30 AM ET Company Participants John Fraunces - Managing Director of LifeSci Advisors, LLC Ryan Rhodes - CEO Ken Mobeck - CFO, U.S. Subsidiary Francois Dietsch - CFO Conference Call Participants Michael Sarcone - Jefferies Frank Takkinen - Lake Street Capital Markets Jason Bednar - Piper Sandler Swayampakula Ramakanth - H.C.
- Company to host conference call and webcast on Thur sday, August 24 th at 8:30 am EDT -
EDAP TMS S.A. shares have pushed lower in H2 FY'23, presenting an opportunity to add on weakness. EDAP's Q1 revenues were up 13.8% YoY, with HIFU sales up around 40% YoY. On examination, sentiment and positioning remains bullish in the stock based on market and options-generated data.
Start Time: 08:30 January 1, 0000 9:10 AM ET EDAP TMS S.A. (NASDAQ:EDAP ) Q1 2023 Earnings Conference Call May 17, 2023, 08:30 AM ET Company Participants Ryan Rhodes - CEO Ken Mobeck - CFO, U.S. Subsidiary Francois Dietsch - CFO John Fraunces - Managing Director of Life Advisors Conference Call Participants Joseph Downing - Piper Sandler Michael Sarcone - Jefferies Sean Lee - H.C.
What type of business is EDAP TMS SA?
EDAP TMS S.A., together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. It operates in three segments: High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST). The HIFU segment develops, manufactures, and markets medical devices based on HIFU technology for the minimally invasive treatment of urological and other clinical indications. This segment also offers Ablatherm, an ultrasound guided robotic HIFU device for the treatment of organ-confined prostate cancer; Ablatherm Fusion that incorporates the company's proprietary fusion software, which merges MRI and ultrasound images; and the Focal One, a HIFU robotic device dedicated to the focal therapy of prostate cancer, as well as disposables, and leasing and treatment related services; and maintenance services. The ESWL division manufactures, markets, and services lithotripter for the treatment of urinary tract stones by means of ESWL technology; and offers Sonolith i-move, an extracorporeal shockwave lithotripter to small and mid-size hospitals, as well as sells disposable parts for lithotripters and electrodes. The Distribution division markets, distributes, and services lasers, micro-ultrasound systems, and other medical products from third parties, as well as leases devices; sells disposables and spare parts; and offers maintenance services. The company markets and sells its products through its direct marketing, sales organization, and service platform, as well as through third-party distributors and agents. Its customers include hospitals, urology clinics, and research institutions. The company was incorporated in 1979 and is headquartered in Lyon, France.
What sector is EDAP TMS SA in?
EDAP TMS SA is in the Healthcare sector
What industry is EDAP TMS SA in?
EDAP TMS SA is in the Medical Distribution industry
What country is EDAP TMS SA from?
EDAP TMS SA is headquartered in France
When did EDAP TMS SA go public?
EDAP TMS SA initial public offering (IPO) was on 01 August 1997
What is EDAP TMS SA website?
https://www.edap-tms.com
Is EDAP TMS SA in the S&P 500?
No, EDAP TMS SA is not included in the S&P 500 index
Is EDAP TMS SA in the NASDAQ 100?
No, EDAP TMS SA is not included in the NASDAQ 100 index
Is EDAP TMS SA in the Dow Jones?
No, EDAP TMS SA is not included in the Dow Jones index
When does EDAP TMS SA report earnings?
The next expected earnings date for EDAP TMS SA is 23 August 2024